• 1
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 1536
  • 2
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zinke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005; 95: 7516
  • 3
    Kupelian P, Thames H, Levy L et al. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 2005; 63: 7959
  • 4
    Chaussy C, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001; 15: 43740
  • 5
    Madersbacher S, Kratzik C, Marberger M. Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application. Ultrason Sonochem 1997; 4: 1759
  • 6
    Rebillard X, Gelet A, Davin JL et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 2005; 19: 693701
  • 7
    Bales GT, Williams MJ, Sinner M, Thisted RA, Chodak GW. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology 1995; 46: 67680
  • 8
    Carroll PR, Presti JC, Small E Jr, Roach M 3rd. Focal therapy for prostate cancer: maximizing outcome. Urology 1997; 49 (Suppl. 3A): 8494
  • 9
    Shinohara K. Prostate cancer: cryotherapy. Urol Clin North Am 2003; 30: 72536
  • 10
    Mutaguchi K, Matsubara A, Kajiwara M et al. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention. Urology 2006; 68: 30711
  • 11
    Yuen JS, Thng CH, Tan PH et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171: 14826
  • 12
    Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5T: initial results. Radiology 2005; 234: 57681
  • 13
    Amsellem-Ouazana D, Younes P, Conquy S et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005; 47: 5826
  • 14
    Perrotti M, Han KR, Epstein RE et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 1999; 162: 13147
  • 15
    Futterer JJ, Heijmink SW, Scheenen TW et al. Prostate cancer: local staging at 3-T endorectal MR imaging – early experience. Radiology 2006; 238: 18491
  • 16
    Futterer JJ, Engelbrecht MR, Huisman HJ et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005; 237: 5419
  • 17
    Kruecker J, Xu S, Glossop N et al. Fusion of real-time trans-rectal ultrasound with pre-acquired MRI for multi-modality prostate Imaging. Proc SPIE 2007: 8752: 891223
  • 18
    Beyersdorff D, Taupitz M, Winkelmann B et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002; 224: 7016
  • 19
    Anastasiadis AG, Lichy MP, Nagele U et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 2006; 50: 73849